Browse Fibrin topic

Subtopics (7)

• Health aspects
• Licensing agreements
• Physiological aspects
• Product development
• Research
• Social aspects
• Usage

Articles

Title	Author	Type	Date	Words
Changes in the activated cytotoxic suppressor T-lymphocytes in elderly patients with mediterranean spotted fever.	Gospodinova, Margarita D.; Nenova, Marina A.; Mileva, Sevda S.	Report	Jul 1, 2009	2906
Alipoyo adds Kalayaan Cup to his FGA major win.			Jun 24, 2009	562
FGA Team A ends Saudi reign in Country Match.			May 21, 2009	736
Angiotech enters license, distribution and supply agreements for fibrin and thrombin technologies with Haemacure Corporation.			May 1, 2009	791
The French Biopharmaceutical Group LFB Has Announced the First-in-Man Injections of Its First Two Therapeutic Monoclonal Antibodies and the Filing of BLAs for a New-Generation Immunoglobulin and a Fibrinogen.			Feb 10, 2009	414
Omrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding.			Oct 24, 2008	450
Omrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human).			Oct 14, 2008	498
Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding.			Oct 9, 2008	386
Omrix Biopharmaceuticals Announces Interim Analysis Indicating Superiority of Fibrin Pad Versus SURGICEL in Mild to Moderate Bleeding In U.S. Phase II Clinical Trial And Provides Update On Additional Fibrin Pad Clinical Trials.			Oct 8, 2008	855
Kuros and Aeris Announce Exclusive License Agreement in the Field of Lung Volume Reduction.			Sep 23, 2008	651
Omrix Biopharmaceuticals Completes Enrollment of Initial 90 Patients Needed to Conduct Interim Analysis in Fibrin Pad U.S. Phase II Clinical Trial.		Clinical report	Sep 22, 2008	666
Omrix Biopharmaceuticals Receives Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for Evicel(TM) Liquid Fibrin Sealant (Human).			Jul 25, 2008	577
Omrix Biopharmaceuticals Initiates Phase II Clinical Trial in Israel for Fibrin Pad Product Candidate.			Jul 2, 2008	653
BRIEFS.			Jun 26, 2008	223
GTC Biotherapeutics Licenses Recombinant Fibrinogen Patents to Pharming.			Jun 25, 2008	503
Command Arms Accessories FGA Flashlight Grip Adaptor.			May 1, 2008	64
OMRIX Biopharmaceuticals Initiates Phase II Clinical Trial for Fibrin Patch Product Candidate.			Mar 27, 2008	397
United States: Omrix Biopharma to begin phase II Clinical trial in US for Fibrin Patch Product candidate.			Mar 19, 2008	138
OMRIX Biopharmaceuticals Provides Update on its Fibrin Patch Product Candidate.			Mar 17, 2008	437
Forticell Bioscience Announces Collaboration Agreement with CJ CheilJedang, a Korean Pharmaceutical Giant to Use Fibrin MicroBeads (FMB(TM)) for Novel Umbilical Cord Blood Stem Cell Recovery.			Jan 14, 2008	1101
OMRIX Biopharmaceuticals Receives FDA Approval for General Hemostasis in Surgery Indication for EVICEL(TM) Liquid Fibrin Sealant (Human).			Jan 10, 2008	702
GTC Biotherapeutics Obtains Licenses to Factor IX, Factor VIII and Fibrinogen.			Dec 5, 2007	801
OMRIX Biopharmaceuticals Announces Positive Phase I Results with Fibrin Patch.			Oct 16, 2007	675
Fibrin glue in thyroid and parathyroid surgery: is under-flap suction still necessary?	Rice, Dale H.		Aug 1, 2006	1552
Effects of Tisseel fibrin glue on the central nervous system of nonhuman primates.	Horowitz, Michael		Apr 1, 2004	4777
Factors influencing pre-eclampsia/eclampsia outcomes in high-risk patients in Zimbabwe.	Mudokwenuy-Rawdon, C.; Bezuidenhout, M.C.; Ehlers, V.J.		Mar 1, 2003	10498
Fibrin glue prevents complications of septal surgery: Findings in a series of 100 patients. (Original Article).	Rice, Dale H.		Mar 1, 2003	1153
Clotting protein hinders nerve repair. (Biomedicine).		Brief Article	Apr 6, 2002	386
Agreements.			Apr 1, 2002	746
SUR1 Fibrin sealant in trauma surgery. (Surgery).		Brief Article	Dec 1, 2001	290
Reinforcement of an end-to-end tracheal resection anastomosis with fibrin glue: A case report.	Huo, Jerry		Apr 1, 2001	1142
Agreements.			Mar 1, 2001	781
Diluted Fibrin Glue for Intractable Pneumothorax.			Sep 1, 2000	546
Peptide blocking of clotting cascade points to thrombosis therapy.			May 1, 2000	875
Coagulation Testing in Hypertensive Disorders of Pregnancy.			Nov 1, 1999	562
Intermittent intravenous therapy: a comparison of two flushing solutions.	Robertson, Jeanette	Report	Dec 1, 1994	2725